SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.4359033

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

55.71

293.5

EPS(TTM)

Face Value()

Div & Yield %

0.97

Back

CRISIL announces cessation of director

Jan 01,2026

CRISIL announced that Shyamala Gopinath (DIN: 02362921) has completed her term as an Independent Director on 31 December 2025, and has consequently ceased to be an Independent Director of the Company with effect from 31 December 2025.

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)